According to investigations, folate-mediated methylation affects genes such as p16, hMLH1, and MGMT, and can alter a patient's vulnerability to breast and colorectal cancers (Chen et al. 2012; Sanchez et al. 2017). This evidence concerns the gene MLH1 and colorectal cancer.